SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-23-120731
Filing Date
2023-11-22
Accepted
2023-11-22 16:02:16
Documents
16
Period of Report
2023-09-29
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2330767d1_8ka.htm   iXBRL 8-K/A 30712
2 EXHIBIT 23.1 tm2330767d1_ex23-1.htm EX-23.1 2699
3 EXHIBIT 99.1 tm2330767d1_ex99-1.htm EX-99.1 249215
4 EXHIBIT 99.2 tm2330767d1_ex99-2.htm EX-99.2 249551
5 EXHIBIT 99.3 tm2330767d1_ex99-3.htm EX-99.3 154853
  Complete submission text file 0001104659-23-120731.txt   948631

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA immu-20230929.xsd EX-101.SCH 3015
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20230929_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20230929_pre.xml EX-101.PRE 22359
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2330767d1_8ka_htm.xml XML 4249
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39580 | Film No.: 231433364
SIC: 2834 Pharmaceutical Preparations